Pharmaceutical Group
This article has multiple issues. Please help
improve it or discuss these issues on the
talk page. (
Learn how and when to remove these template messages)
This article may be written from a
fan's point of view, rather than a
neutral point of view. Please
clean it up to conform to a
higher standard of quality, and to make it neutral in tone. (June 2021) (
Learn how and when to remove this template message)
A major contributor to this article appears to have a
close connection with its subject. It may require cleanup to comply with Wikipedia's content policies, particularly
neutral point of view. Please discuss further on the
talk page. (June 2021) (
Learn how and when to remove this template message)
.mw-parser-output .hidden-begin{box-sizing:border-box;width:100%;padding:5px;border:none;font-size:95%}.mw-parser-output .hidden-title{font-weight:bold;line-height:1.6;text-align:left}.mw-parser-output .hidden-content{text-align:left}@media all and (max-width:500px){.mw-parser-output .hidden-begin{width:auto!important;clear:none!important;float:none!important))You can help expand this article with text translated from
the corresponding article in Chinese. Click [show] for important translation instructions.
View a machine-translated version of the Chinese article.
Machine translation, like
DeepL or
Google Translate, is a useful starting point for translations, but translators must revise errors as necessary and confirm that the translation is accurate, rather than simply copy-pasting machine-translated text into the English Wikipedia.
Consider
adding a topic to this template: there are already 338 articles in the
main category, and specifying|topic= will aid in categorization.
Do not translate text that appears unreliable or low-quality. If possible, verify the text with references provided in the foreign-language article.
You must provide
copyright attribution in the
edit summary accompanying your translation by providing an
interlanguage link to the source of your translation. A model attribution edit summary is Content in this edit is translated from the existing Chinese Wikipedia article at [[:zh:康弘药业]]; see its history for attribution.
You should also add the template ((Translated|zh|康弘药业)) to the
talk page.
For more guidance, see
Wikipedia:Translation.
(
Learn how and when to remove this template message)
Chengdu Kanghong Pharmaceutical Group Co., Ltd. is a publicly traded pharmaceutical company based in the province of Sichuan, China.[1] It was founded in 1996 and researches, develops, manufactures, and distributes medicines[2] for ophthalmic, central nervous, digestive and endocrine systems.[1] The company is listed on the Shenzhen stock exchange with a market capitalization at around $6 billion.[3][4]
As of May 2021, the company had 18 drugs on the market including Lumitin (conbercept).[5] Additional products include Songling xuemaikang capsules, Keluoxin capsules, Xinluona (Mosapride Citrate), Bolexin (Venlafaxine hydrochloride capsules) and Bosiqing (Aripiprazole tablets), Yitaning (Dexzopiclone tablets), Shugan Jieyu (capsules), Danshu (capsules), and Yiqing (capsules).[2][6] Kanghong also currently has 13 subsidiaries in China, Israel, and the United States.[7]
History
In 2005, Kanghong started development of the drug conbercept, which is used to treat age-related macular degeneration (AMD).[1] In 2017, Kanghong acquired IOPtima, a subsidiary of BioLight Israeli Life Sciences Investment.[4] Kanghong also became a distributor of IOPtima’s products in China.[4]
In 2016, Kanghong received approval from the U.S. FDA to begin Phase III clinical trials of conbercept. In 2020, the company’s R&D investments were approximately 29% of its annual revenue,[8] and by 2020, the company held 238 patents and exclusive patents for 13 drugs out of their 18 products.[5]
As of December 2020, the company’s drugs in development are for treatment of various diseases and conditions including glioma, fundus disease tumors, diabetic macular edema (DME), and Type II diabetes.[9]
During the COVID-19 pandemic, Kanghong donated money, protective clothing, and other materials to medical institutions across China through the China Red Cross Foundation.[10][11]